Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular Blood Flow Effects of Topically-administered Unoprostone in Adults with Age-related Macular Degeneration
2010-024169-33Phase 2Completed
- Sponsor
- Sucampo Pharmaceuticals
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of unoprostone isopropyl in age-related macular degeneration (AMD) (2 arms), sponsored by Sucampo Pharmaceuticals. Primary endpoint: Choroidal blood flow by laser Doppler flowmetry. Started Dec 2010; status: completed.
02
Drugs
unoprostone isopropyl
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2010-024169-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024169-33.